Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Trygve Talseth

102 publications found

Original articles

Andersen AV, Granlund P, Schultz A, Talseth T, Hedlund H, Frich L (2012)
Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis
Scand J Urol Nephrol, 46 (4), 284-9
DOI 10.3109/00365599.2012.669789, PubMed 22452583

Jensen D, Aasen S, Talseth T (2006)
Uroflowmetry with simultaneous electromyography versus voiding video cystourethrography
Scand J Urol Nephrol, 40 (3), 232-7
DOI 10.1080/00365590600641590, PubMed 16809266

Tønseth KA, Schultz A, Talseth T, Hedlund H (2005)
[Treatment of erectile dysfunction with penile implants]
Tidsskr Nor Laegeforen, 125 (13), 1825-7
PubMed 16012552

Seim A, Talseth T, Haukeland H, Høye K, Berg N, Bergeland T (2004)
Validation of a simple patient questionnaire to assist self-detection of overactive bladder. A study in general practice
Scand J Prim Health Care, 22 (4), 217-21
DOI 10.1080/02813430410006639, PubMed 15765636

Schultz A, Hedlund H, Talseth T (2003)
[Expandable penile implants in patients with erectile dysfunction]
Tidsskr Nor Laegeforen, 123 (17), 2449-50
PubMed 14562782

Hedlund H, Schultz A, Talseth T, Tonseth K, van der Hagen A (2002)
Sacral neuromodulation in Norway: clinical experience of the first three years
Scand J Urol Nephrol Suppl (210), 87-95
DOI 10.1080/003655902320766024, PubMed 12475023

Bø K, Lilleås F, Talseth T, Hedland H (2001)
Dynamic MRI of the pelvic floor muscles in an upright sitting position
Neurourol Urodyn, 20 (2), 167-74
DOI 10.1002/1520-6777(2001)20:2<167::aid-nau19>3.0.co;2-4, PubMed 11170191

Hedlund H, Bø K, Lilleås F, Talseth T, Tillung T (2001)
The clinical value of dynamic magnetic resonance imaging in normal and incontinent women--a preliminary study on micturition
Scand J Urol Nephrol Suppl (207), 87-91; discussion 106-25
DOI 10.1080/003655901750174999, PubMed 11409620

Bø K, Talseth T, Vinsnes A (2000)
Randomized controlled trial on the effect of pelvic floor muscle training on quality of life and sexual problems in genuine stress incontinent women
Acta Obstet Gynecol Scand, 79 (7), 598-603
DOI 10.1034/j.1600-0412.2000.079007598.x, PubMed 10929962

Angelsen A, Talseth T, Mjønes JG, Hedlund H (2000)
Hypertension and pseudoaneurism on the renal artery following retrograde endopyelotomy (Acucise)
Scand J Urol Nephrol, 34 (1), 79-80
DOI 10.1080/003655900750016977, PubMed 10757279

Bø K, Talseth T, Holme I (1999)
Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women
BMJ, 318 (7182), 487-93
DOI 10.1136/bmj.318.7182.487, PubMed 10024253

Talseth T, Hedlund H (1997)
[Benign prostatic hyperplasia. Shared care between urologists and general practitioners]
Tidsskr Nor Laegeforen, 117 (3), 389-93
PubMed 9064864

Bø K, Talseth T (1997)
Change in urethral pressure during voluntary pelvic floor muscle contraction and vaginal electrical stimulation
Int Urogynecol J Pelvic Floor Dysfunct, 8 (1), 3-6; discussion 6-7
DOI 10.1007/BF01920286, PubMed 9260089

Bø K, Talseth T (1996)
Long-term effect of pelvic floor muscle exercise 5 years after cessation of organized training
Obstet Gynecol, 87 (2), 261-5
DOI 10.1016/0029-7844(95)60375-1, PubMed 8559536

Schultz A, Talseth T (1996)
Continent urinary diversion in patients with dysfunction of the lower urinary tract. Experience with the detubularized right colonic segment as urinary reservoir.
Scand. J. Urol. Nephrol., 30 179, 93-96

Klevmark B, Andersen M, Schultz A, Talseth T (1994)
Congenital and acquired curvature of the penis treated surgically by plication of the tunica albuginea
Br J Urol, 74 (4), 501-6
DOI 10.1111/j.1464-410x.1994.tb00431.x, PubMed 7820431

Westlie L, Fauchald P, Talseth T, Jakobsen A, Flatmark A (1993)
Quality of life in Norwegian kidney donors
Nephrol Dial Transplant, 8 (10), 1146-50
PubMed 7818616

Hartmann A, Holdaas H, Fauchald P, Nordal KP, Berg KJ, Talseth T, Leivestad T, Brekke IB, Flatmark A (1992)
Fifteen years' experience with renal transplantation in systemic amyloidosis
Transpl Int, 5 (1), 15-8
DOI 10.1007/BF00337183, PubMed 1580980

Talseth T, Westlie L, Daae L (1991)
Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up
Am Heart J, 121 (1 Pt 2), 280-5
DOI 10.1016/0002-8703(91)90858-f, PubMed 1824651

Kvittingen EA, Talseth T, Halvorsen S, Jakobs C, Hovig T, Flatmark A (1991)
Renal failure in adult patients with hereditary tyrosinaemia type I
J Inherit Metab Dis, 14 (1), 53-62
DOI 10.1007/BF01804389, PubMed 1861460

Talseth T, Westlie L, Daae L (1990)
A long-term study of atenolol and doxazosin in mild and moderate hypertension
J Hum Hypertens, 4 Suppl 3, 39-44
PubMed 2148194

Talseth T, Westlie L, Daae LN (1990)
Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers
J Hypertens Suppl, 8 (5), S47-51
PubMed 1981077

Albrechtsen D, Sødal G, Jakobsen A, Brekke I, Bentdal O, Berg KJ, Fauchald P, Pfeffer P, Talseth T, Leivestad T (1990)
Kidney transplantation from a spouse: an alternative to years of dialysis waiting for a graft that may never turn up?
Transplant Proc, 22 (4), 1435
PubMed 2389351

Riddervold F, Forslund T, Endresen K, Simonsen S, Talseth T, Fyhrquist F (1990)
Hormonal changes during tilt and atrial pacing in heart transplant patients
Transplant Proc, 22 (1), 191-4
PubMed 2137947

Albrechtsen D, Bentdal O, Berg KJ, Brekke I, Fauchald P, Jakobsen A, Pfeffer P, Sødal G, Talseth T, Flatmark A (1990)
Infections in cyclosporine-treated kidney graft recipients: beneficial effect of cotrimoxazole prophylaxis
Transplant Proc, 22 (1), 245
PubMed 2309322

Holdaas H, Hartmann A, Talseth T, Fauchald P, Sødal G, Brekke IB, Berg KJ (1990)
Change in intrarenal sodium reabsorption following donor nephrectomy
Transplant Proc, 22 (1), 246
PubMed 2309323

Albrechtsen D, Berg KJ, Brekke I, Fauchald P, Jakobsen A, Sødal G, Talseth T, Leivestad T, Flatmark A (1990)
Renal replacement therapy in the cyclosporine era: results of a national transplantation program
Transplant Proc, 22 (1), 155-6
PubMed 2309295

Kolbenstvedt A, Egge T, Klevmark B, Talseth T (1990)
Isolated cavernous bodies
J Urol, 143 (2), 356-7
DOI 10.1016/s0022-5347(17)39961-5, PubMed 2299731

Jakobsen A, Albrechtsen D, Leivestad T, Sødal G, Talseth T, Flatmark A (1990)
Steroid-resistant rejection: the effect of ATG on renal allograft survival
Transplant Proc, 22 (1), 225
PubMed 2309320

Albrechtsen D, Sødal G, Jakobsen A, Brekke I, Flatmark A, Fauchald P, Talseth T, Thorsby E (1990)
[Kidney transplantation in Norway]
Tidsskr Nor Laegeforen, 110 (3), 327-31
PubMed 2309172

Fauchald P, Joachim Berg K, Brodwall EK, Talseth T, Flatmark A, Leivestad T, Halvorsen S (1990)
[Treatment of chronic kidney failure with dialysis and transplantation. Development, need and organization in Norway]
Tidsskr Nor Laegeforen, 110 (3), 332-4
PubMed 2309173

Holdaas H, Brekke IB, Hartmann A, Talseth T, Sødal G, Jervell J, Flatmark A (1989)
Long-term metabolic control in recipients of duct-occluded segmental pancreatic grafts
Transplant Proc, 21 (1 Pt 3), 2854-5
PubMed 2650384

Berg KJ, Gjellestad A, Nordby G, Rootwelt K, Djøseland O, Fauchald P, Mehl A, Narverud J, Talseth T (1989)
Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients
Nephron, 53 (3), 218-22
DOI 10.1159/000185747, PubMed 2677807

Talseth T, Westlie L, Daae L, Vatle S (1988)
Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients
Am Heart J, 116 (6 Pt 2), 1790-6
DOI 10.1016/0002-8703(88)90231-1, PubMed 2904752

Fauchald P, Albrechtsen D, Leivestad T, Berg KJ, Talseth T, Flatmark A (1988)
Renal replacement therapy in elderly patients
Transpl Int, 1 (3), 131-4
DOI 10.1007/BF00348834, PubMed 3075472

Holdaas H, Hartmann A, Talseth T, Berg KJ, Fauchald P, Stenstrøm J, Djøseland O, Nordal KP, Brodwall E (1988)
Short-term changes in renal function of the remaining kidney after donor nephrectomy
Transplant Proc, 20 (3), 434-5
PubMed 3381255

Holdaas H, Talseth T, Berg KJ, Fauchald P, Nordal KP, Hartmann A (1988)
Diagnostic value of peripheral plasma renin response to a single dose of captopril in suspected renal transplant artery stenosis
Transplant Proc, 20 (3), 423-4
PubMed 3289174

Fauchald P, Albrechtsen D, Leivestad T, Pfeffer P, Talseth T, Flatmark A (1988)
Renal replacement therapy in patients over 60 years of age
Transplant Proc, 20 (3), 432-3
PubMed 3289177

Talseth T, Holdaas H, Albrechtsen D, Berg KJ, Fauchald P, Naalsund A, Nordal KP, Skar AG, Sødal G, Flatmark A (1988)
Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients
Transplant Proc, 20 (3), 400-1
PubMed 3289169

Berg KJ, Nordby G, Rootwelt K, Djøseland O, Fauchald P, Mehl A, Narverud J, Talseth T (1988)
Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients
Transplant Proc, 20 (3), 413-5
PubMed 3289171

Klevmark B, Talseth T, Eri LM, Kolbenstvedt AN (1988)
[Erectile impotence and disorders of venous circulation]
Tidsskr Nor Laegeforen, 108 (8-9), 679-80
PubMed 3353971

Klevmark B, Talseth T, Eri LM, Borchgrevink HH, Kolbenstvedt A (1988)
[Congenital curvature of the erect penis without simultaneous changes in the urethra or corpus spongiosum and with normal erection]
Tidsskr Nor Laegeforen, 108 (8-9), 683-5
PubMed 3353973

Hem E, Tveter KJ, Karlsen S, Sander S, Talseth T, Klevmark B, Sundby K (1988)
[Shock wave therapy of urolithiasis. Norwegian experiences]
Tidsskr Nor Laegeforen, 108 (5), 382-6
PubMed 3353931

ALBRECHTSEN D, FAUCHALD P, LEIVESTAD T, TALSETH T, FLATMARK A (1988)
RENAL REPLACEMENT THERAPY IN ELDERLY PATIENTS
Transplant. Proc., 20 (1 1), 367-369

Klevmark B, Talseth T, Eri LM, Kolbenstvedt A, Egge T (1988)
Abnormal venous drainage from the penis examined by dynamic cavernosography and surgically treated
Scand J Urol Nephrol Suppl, 110, 261-5
PubMed 3187421

Fauchald P, Leivestad T, Bratlie A, Albrechtsen D, Talseth T, Flatmark A (1987)
Plasma exchange and immunosuppressive therapy before renal transplantation in allosensitized patients
Transplant Proc, 19 (5), 3748-9
PubMed 3313908

Sødal G, Albrechtsen D, Berg KJ, Bondevik H, Brekke IB, Fauchald P, Jakobsen A, Talseth T, Thorsby E, Flatmark A (1987)
Renal transplantation from living donors mismatched for two HLA haplotypes
Transplant Proc, 19 (1 Pt 2), 1509-10
PubMed 3079022

Talseth T, Westre B, Bondevik H, Albrechtsen D (1987)
Prognostic information in biopsies of transplanted kidneys with unsatisfactory response to antirejection therapy
Transplant Proc, 19 (1 Pt 2), 1623-4
PubMed 2484096

ALBRECHTSEN D, BERG KJ, BONDEVIK H, BREKKE IB, FAUCHALD P, JAKOBSEN A, SODAL G, TALSETH T, FLATMARK A (1986)
PROGNOSTIC FACTORS IN AZATHIOPRINE-TREATED AND CYCLOSPORINE-TREATED RECIPIENTS OF CADAVERIC RENAL-TRANSPLANTS
Transplant. Proc., 18 (5), 1073-1076

Strømme JH, Haffner F, Johannessen NB, Talseth T, Frederichsen P, Theodorsen L (1986)
Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods
Scand J Clin Lab Invest, 46 (5), 443-50
DOI 10.3109/00365518609083696, PubMed 2428093

Talseth T, Fauchald P, Skrede S, Djøseland O, Berg KJ, Stenstrøm J, Heilo A, Brodwall EK, Flatmark A (1986)
Long-term blood pressure and renal function in kidney donors
Kidney Int, 29 (5), 1072-6
DOI 10.1038/ki.1986.109, PubMed 3523003

ALBRECHTSEN D, BERG KJ, BONDEVIK H, BREKKE IB, FAUCHALD P, JAKOBSEN A, MOEN T, SODAL G, TALSETH T, THORSBY E, FLATMARK A (1986)
IMPROVED RESULTS USING CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANTATION
Transplant. Proc., 18 (1), 92-94

TALSETH T, FAUCHALD P, FLATMARK A (1986)
THE LONG-TERM PROGNOSIS OF LIVING KIDNEY DONORS
Transplant. Proc., 18 (1), 106-107

Nilssen DE, Talseth T, Brodwall EK (1986)
The many faces of Goodpasture's syndrome
Acta Med Scand, 220 (5), 489-91
DOI 10.1111/j.0954-6820.1986.tb02800.x, PubMed 3492866

Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1986)
Self-poisoning and moon phases in Oslo
Hum Toxicol, 5 (1), 51-2
DOI 10.1177/096032718600500110, PubMed 3949368

Ekholdt PF, Gulsvik A, Digranes S, Hovig T, Mellbye OJ, Talseth T (1985)
Recurrent diffuse pulmonary hemorrhage with minor kidney lesions
Eur J Respir Dis, 66 (5), 353-9
PubMed 3874785

Berg KJ, Talseth T (1985)
Acute renal effects of sulindac and indomethacin in chronic renal failure
Clin Pharmacol Ther, 37 (4), 447-52
DOI 10.1038/clpt.1985.69, PubMed 3884224

Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1984)
A prospective study of 1212 cases of acute poisoning: general epidemiology
Hum Toxicol, 3 (2), 93-106
DOI 10.1177/096032718400300203, PubMed 6724595

Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1984)
Clinical course in acute self-poisonings: a prospective study of 1125 consecutively hospitalised adults
Hum Toxicol, 3 (2), 107-16
DOI 10.1177/096032718400300204, PubMed 6724591

Vatn MH, Schrumpf E, Talseth T (1983)
Effect of cimetidine on intrinsic factor secretion stimulated by different doses of pentagastrin in patients with impaired renal function
Scand J Gastroenterol, 18 (8), 1109-14
DOI 10.3109/00365528309181849, PubMed 6424229

Ulrichsen H, Fauchald P, Talseth T (1983)
[Experiences of a subclavian catheter in hemodialysis]
Tidsskr Nor Laegeforen, 103 (27), 1876-8
PubMed 6648924

Talseth T, Schrumpf E, Ulrichsen H (1983)
Acute effects of intravenous cimetidine upon gastric secretion in patients with impaired renal function
Nephron, 33 (4), 244-7
DOI 10.1159/000182961, PubMed 6405296

Clementi WA, McNay JL, Talseth T, Haegele KD, Ludden TM, Musgrave GE (1982)
Endogenous generation of hydralazine from labile hydralazine hydrazones
J Pharmacol Exp Ther, 222 (1), 159-65
PubMed 7086698

Talseth T, McNay JL, Haegele KD (1982)
Hypotensive effect of the hydralazine--acetone hydrazone in conscious rabbits: evidence for its back-conversion to hydralazine in vivo
J Cardiovasc Pharmacol, 4 (3), 370-4
DOI 10.1097/00005344-198205000-00005, PubMed 6177931

Talseth T, Kongerud J, Boye NP, Bredesen JE (1981)
[Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease]
Tidsskr Nor Laegeforen, 101 (29), 1648-50
PubMed 7339948

Talseth T, Boye NP, Bredesen JE, Kornstad S (1981)
A comparison of the plasma profiles of two slow-release theophylline preparations (Nuelin depot and Theo-dur) in healthy volunteers
Ann Allergy, 46 (5), 279-80
PubMed 7235323

Talseth T, Boye NP, Kongerud J, Bredesen JE (1981)
Aging, cigarette smoking and oral theophylline requirement
Eur J Clin Pharmacol, 21 (1), 33-7
DOI 10.1007/BF00609585, PubMed 7333344

Talseth T, McNay JL, Ballinger K, Clementi WA, Shepherd AM (1981)
Vasoconstriction limits to the use of the central ear artery pressure in conscious rabbits
Lab Anim, 15 (1), 1-3
DOI 10.1258/002367781780958667, PubMed 7265889

Talseth T, Kornstad S, Boye NP, Bredesen JE (1981)
Individualization of oral theophylline dosage in elderly patients
Acta Med Scand, 210 (6), 489-92
DOI 10.1111/j.0954-6820.1981.tb09856.x, PubMed 7331897

Haegele KD, Talseth T, Skrdlant HB, Shepherd AM, Huff SL (1981)
Determination of hydralazine pyruvic acid hydrazone and its correlation with "apparent" hydralazine
Arzneimittelforschung, 31 (2), 357-62
PubMed 7194654

TALSETH T, KORNSTAD S, BOYE NP (1981)
MINOR SIDE-EFFECTS FROM ORAL THEOPHYLLINE - RELATIONSHIP WITH PLASMA THEOPHYLLINE CONCENTRATIONS
Curr. Ther. Res.-Clin. Exp., 30 (1), 63-70

Talseth T, McNay JL, Clementi WA (1980)
Route and rate of hydrallazine administration as determinants to its hypotensive effect in rabbits
Clin Exp Pharmacol Physiol, 7 (4), 403-6
DOI 10.1111/j.1440-1681.1980.tb00089.x, PubMed 7418274

Talseth T (1980)
[Colitis cystica profunda]
Tidsskr Nor Laegeforen, 100 (8-9), 493-5
PubMed 7385206

Haegele KD, Skrdlant HB, Talseth T, McNay JL, Shepherd AM, Clementi WA (1980)
Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazine
J Chromatogr, 187 (1), 171-9
DOI 10.1016/s0021-9673(00)87883-8, PubMed 7358814

Talseth T, Haegele KD, McNay JL (1980)
Studies in the rabbit on 3-methyltriazolophthalazine, an acetylated metabolite of hydralazine. Evidence for an alternative route of formation
Drug Metab Dispos, 8 (2), 73-6
PubMed 6103791

Talseth T, Boye NP, Bredesen JE (1979)
Clinical and pharmacological observations on a new microcrystalline theophylline preparation
Scand J Respir Dis, 60 (6), 358-66
PubMed 538420

Talseth T, Haegele KD, McNay JL, Skrdlant HB, Clementi WA, Shepherd AM (1979)
Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone
J Pharmacol Exp Ther, 211 (3), 509-13
PubMed 512915

Shepherd AM, Ludden TM, Haegele KD, Talseth T, McNay JL (1979)
Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans
Res Commun Chem Pathol Pharmacol, 26 (1), 129-44
PubMed 515498

Talseth T, Eika C (1978)
[Protracted glibenclamide induced hypoglycemia]
Tidsskr Nor Laegeforen, 98 (19-21), 949-50
PubMed 98861

Talseth T (1978)
Inflammatory tumours in the rectum clinically simulating cancer
Acta Chir Scand, 144 (5), 321-3
PubMed 735668

Talseth T, Boye NP, Bredesen JE, Lunde PK (1977)
[Intravenous influsion of theophyllamine]
Tidsskr Nor Laegeforen, 97 (29), 1511-13
PubMed 918923

Talseth T (1977)
Kinetics of hydralazine elimination
Clin Pharmacol Ther, 21 (6), 715-20
DOI 10.1002/cpt1977216715, PubMed 862310

Talseth T, Fauchald P, Pape JF (1977)
Hydralazine slow-release: observations on serum profile and clinical efficacy in man
Curr Ther Res Clin Exp, 21 (2), 157-68
PubMed 403050

Talseth T (1977)
Clinical pharmacokinetics of hydrallazine
Clin Pharmacokinet, 2 (5), 317-29
DOI 10.2165/00003088-197702050-00001, PubMed 913002

Talseth T, Landmark KH (1977)
Polymorphic acetylation of sulphadimidine in normal and uraemic man
Eur J Clin Pharmacol, 11 (1), 33-6
DOI 10.1007/BF00561785, PubMed 832655

Talseth T (1976)
Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function
Eur J Clin Pharmacol, 10 (5), 311-7
DOI 10.1007/BF00565619, PubMed 976304

Talseth T (1976)
Studies on hydralazine. III. Bioavailability of hydralazine in man
Eur J Clin Pharmacol, 10 (6), 395-401
DOI 10.1007/BF00563075, PubMed 1001354

TALSETH T (1976)
STUDIES ON HYDRALAZINE .1. SERUM CONCENTRATIONS OF HYDRALAZINE IN MAN AFTER A SINGLE DOSE AND AT STEADY-STATE
Eur. J. Clin. Pharmacol., 10 (3-4), 183-187
DOI 10.1007/BF00558327

Talseth T (1976)
Isolated gastric involvement in Crohn's disease. Report of a case simulating scirrhus carcinoma
Acta Chir Scand, 142 (8), 611-3
PubMed 202129

Talseth T, Storstein O (1975)
[Letter: Roentgenologic examination of heart volume]
Tidsskr Nor Laegeforen, 95 (33), 1943
PubMed 1188914

Sanderud A, Talseth T (1970)
[Breast neoplasms]
Nord Med, 84 (32), 1021
PubMed 5453732